726185-54-2 Usage
Uses
Used in Pharmaceutical Industry:
3-PIPERIDIN-4-YL-BENZOIC ACID METHYL ESTER HCL is used as a pharmaceutical intermediate for the synthesis of drugs targeting the central nervous system. Its structural features allow for the creation of compounds with potential therapeutic effects on neurological and psychiatric disorders.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3-PIPERIDIN-4-YL-BENZOIC ACID METHYL ESTER HCL serves as a key building block in the design and development of novel therapeutic agents. Its chemical properties make it suitable for further functionalization and optimization to enhance drug efficacy and safety.
Used in Drug Solubility Enhancement:
The hydrochloride salt form of 3-PIPERIDIN-4-YL-BENZOIC ACID METHYL ESTER HCL is used to improve the solubility of drugs in aqueous environments. This increased solubility is crucial for the formulation of medications that require dissolution in body fluids for effective absorption and distribution.
Used in Drug Stability Improvement:
3-PIPERIDIN-4-YL-BENZOIC ACID METHYL ESTER HCL, in its hydrochloride form, contributes to the stability of pharmaceutical compounds. This stability is essential for maintaining the integrity and potency of drugs throughout their shelf life and during various stages of pharmaceutical processing and storage.
Check Digit Verification of cas no
The CAS Registry Mumber 726185-54-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,6,1,8 and 5 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 726185-54:
(8*7)+(7*2)+(6*6)+(5*1)+(4*8)+(3*5)+(2*5)+(1*4)=172
172 % 10 = 2
So 726185-54-2 is a valid CAS Registry Number.
726185-54-2Relevant academic research and scientific papers
Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereof
-
Page 32, (2008/06/13)
The present invention relates to carboxylic acids and esters of general formula wherein Ar, R, R1, X1, X3, X4, Y and Y1 are defined as in claim 1, the tautomers, the diastereomers, the enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof, as well as the use thereof for the production and purification of antibodies and as labelled compounds in RIA and ELISA assays and as diagnostic or analytical aids in neurotransmitter research.
